BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 1282174)

  • 1. Pharmacokinetic profile of nicorandil in humans: an overview.
    Frydman A
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S34-44. PubMed ID: 1282174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of nicorandil.
    Frydman AM; Chapelle P; Diekmann H; Bruno R; Thebault JJ; Bouthier J; Caplain H; Ungethuem W; Gaillard C; Le Liboux A
    Am J Cardiol; 1989 Jun; 63(21):25J-33J. PubMed ID: 2525322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of nicorandil, a new coronary vasodilator, in dogs.
    Ishizaki T; Chiba K; Suganuma T; Sasaki T; Kamiyama H; Nakano H
    J Pharm Sci; 1984 Apr; 73(4):494-8. PubMed ID: 6233416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacokinetics and pharmacodynamics of linagliptin.
    Graefe-Mody U; Retlich S; Friedrich C
    Clin Pharmacokinet; 2012 Jul; 51(7):411-27. PubMed ID: 22568694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A modified product inhibition model describes the nonlinear pharmacokinetics of nicorandil in rats.
    Bachert EL; Li ZW; Zhao L; Chung SJ; Fung HL
    Pharm Res; 1994 Aug; 11(8):1190-8. PubMed ID: 7971723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E; Cloyd J; Critchley D; Fuseau E
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of nicorandil in patients with normal and impaired renal function.
    Molinaro M; Villa G; Regazzi MB; Salvadeo A; Segagni S; Rondanelli R; Sartirana E
    Eur J Clin Pharmacol; 1992; 42(2):203-7. PubMed ID: 1535591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of ethylene glycol. III. Plasma disposition and metabolic fate after single increasing intravenous, peroral, or percutaneous doses in the male Sprague-Dawley rat.
    Frantz SW; Beskitt JL; Tallant MJ; Zourelias LA; Ballantyne B
    Xenobiotica; 1996 May; 26(5):515-39. PubMed ID: 8736063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefetamet pivoxil clinical pharmacokinetics.
    Blouin RA; Stoeckel K
    Clin Pharmacokinet; 1993 Sep; 25(3):172-88. PubMed ID: 8222459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacokinetics of low-dose pulse methotrexate in rheumatoid arthritis.
    Bannwarth B; Péhourcq F; Schaeverbeke T; Dehais J
    Clin Pharmacokinet; 1996 Mar; 30(3):194-210. PubMed ID: 8882301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients.
    Staatz CE; Tett SE
    Clin Pharmacokinet; 2007; 46(1):13-58. PubMed ID: 17201457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacokinetics of cerivastatin.
    Mück W
    Clin Pharmacokinet; 2000 Aug; 39(2):99-116. PubMed ID: 10976657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of CM 57755, a new histamine H2-receptor antagonist, after single oral doses in man.
    Necciari J; Mery D; Garriot P; Escourrou J; Cautreels W
    Int J Clin Pharmacol Res; 1985; 5(6):457-65. PubMed ID: 2869002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacokinetics of mycophenolate mofetil.
    Bullingham RE; Nicholls AJ; Kamm BR
    Clin Pharmacokinet; 1998 Jun; 34(6):429-55. PubMed ID: 9646007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic profile of dexloxiglumide.
    Persiani S; D'Amato M; Jakate A; Roy P; Wangsa J; Kapil R; Rovati LC
    Clin Pharmacokinet; 2006; 45(12):1177-88. PubMed ID: 17112294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of pantoprazole in man.
    Huber R; Hartmann M; Bliesath H; Lühmann R; Steinijans VW; Zech K
    Int J Clin Pharmacol Ther; 1996 May; 34(5):185-94. PubMed ID: 8738854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The haemodynamic effects and pharmacokinetics of intravenous nicorandil in healthy volunteers.
    Wolf DL; Ferry JJ; Hearron AE; Froeschke MO; Luderer JR
    Eur J Clin Pharmacol; 1993; 44(1):27-33. PubMed ID: 8436151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacokinetics of tenoxicam.
    Nilsen OG
    Clin Pharmacokinet; 1994 Jan; 26(1):16-43. PubMed ID: 8137596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and biochemistry studies on nicotinamide in the mouse.
    Stratford MR; Dennis MF
    Cancer Chemother Pharmacol; 1994; 34(5):399-404. PubMed ID: 8070006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of oxicam nonsteroidal anti-inflammatory agents.
    Olkkola KT; Brunetto AV; Mattila MJ
    Clin Pharmacokinet; 1994 Feb; 26(2):107-20. PubMed ID: 8162655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.